What changed

The regulatory conversation is getting more specific. That usually means buyers need stronger documentation, clearer ownership, and fewer mystery tools touching clinical workflows.

The guidance is about classification, but the operational lesson is bigger

On March 11, 2026, the FDA held a town hall on its final Clinical Decision Support Software guidance, which had been issued in January 2026 and then re-issued later that month. The guidance clarifies which CDS functions can qualify as non-device software and which remain device software under existing digital health policies.

For providers and MSPs, the practical takeaway is straightforward: if software is influencing care decisions, somebody needs to understand what it does, what data it depends on, how updates are controlled, and where human review sits. "The vendor said it was compliant" is not a serious operating model, and the regulator is politely signaling that everyone should stop pretending it is.

Medical AI support now needs documentation, validation, and change discipline

A clinic or specialty practice adopting CDS or AI-supported workflows should know which tools are advisory, which are workflow aids, which fall into regulated territory, and how those distinctions affect training, documentation, and oversight. That is not overkill. It is basic survivability once software starts influencing real clinical work.

This is exactly where a competent MSP can help. Not by practicing medicine, obviously, and that would be a terrible marketing experiment, but by putting the technical controls, inventory discipline, access governance, and change management around the tools clinicians are being asked to trust.

The practical question is whether anyone can explain the system under pressure

If a practice cannot explain what a tool does, which data it uses, who can update it, and how human review fits into the process, then the technical side is already under-governed. Buyers do not need to memorize FDA guidance to feel that risk. They feel it the first time a vendor update lands with no paper trail.

That is why better governance is not just a compliance story. It is a stability story, and that makes it part of the MSP conversation.